France· FR:60870205
VILDAGLIPTINE ZYDUS 50 mg, comprimé
A vildagliptin product containing vildagliptine, registered in France by ZYDUS FRANCE, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Vildagliptin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Vildagliptin · ATC A10BH02
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of vildagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.
- France: $0.32 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Vildagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.98
- IT Italy$1.0
- FR France$0.32
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VILDAGLIPTINE
- Manufacturer
- ZYDUS FRANCE
- Country
- France (FR)
- ATC code
- A10BH02
- ATC class
- Vildagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930244043plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s)EUR 4.22
- cip133400930244067plaquette(s) OPA : polyamide orienté aluminium PVC de 60 comprimé(s)EUR 8.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vildagliptin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- SpainGALVUS 50 mg COMPRIMIDOSNovartis Europharm Limited
- United KingdomGalvus 50mg tabletsMawdsley-Brooks & Company Ltd
- PolandAgnisBelupo lijekovi i kozmetika d.d.
- ItalyGALVUSNOVARTIS EUROPHARM LTD
- SwedenDalmevin 50 mg TablettMedochemie Ltd
- NetherlandsGalvus 50 mg tabletten, tablettenNovartis Europharm Limited
- FinlandGalvusNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Melkart, Saxotin
- Belgium · Vildagliptin Krka
- Bulgaria · Глипвило, Далмевин
- Cyprus · Aglimon, Dalmevin
- Czechia · Alikval, Anvildis
- Germany · Vildabetes, Vildagliptin Al
- Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
- Estonia · Dalmevin, Glypvilo
- Spain · Vildagliptina, Vildagliptina Alter
- Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
- United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
- Greece · Dalmevin, Varbos
- Croatia · Agnis, Dalmevin
- Hungary · Agartha, Alikval
- Ireland · Vildagliptin Krka
- Iceland · Galvus, Jalra
- Italy · Vildagliptin Accord, Vildagliptin Aurobindo
- Liechtenstein · Galvus, Jalra
- Lithuania · Dalmevin, Glypvilo
- Latvia · Dalmevin, Glypvilo
- Malta · Alikval, Dalmevin
- Netherlands · Vilanov, Vildagliptine Accord
- Norway · Galvus, Jalra
- Poland · Anvildis, Diptivil
- Portugal · Tutecvi, Vezagla
- Romania · Agartha, Dalmevin
- Sweden · Dalmevin, Kwikaton
- Slovenia · Glypvilo
- Slovakia · Anvildis, Dalmevin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbcd7f24-3320-4bd2-951e-3c788fd1e75e GET /v1/drugs/fbcd7f24-3320-4bd2-951e-3c788fd1e75e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60870205",
"date_amm": "2021-12-22",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "VILDAGLIPTINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.